395 related articles for article (PubMed ID: 25402189)
1. False-positive lupus anticoagulant in patients receiving rivaroxaban: 24 h since the last dose are needed to exclude antiphospholipid syndrome.
Góralczyk T; Iwaniec T; Wypasek E; Undas A
Blood Coagul Fibrinolysis; 2015 Jun; 26(4):473-5. PubMed ID: 25402189
[TBL] [Abstract][Full Text] [Related]
2. Lupus anticoagulant diagnosis in patients receiving direct oral FXa inhibitors at trough levels: A real-life study.
Gay J; Duchemin J; Imarazene M; Fontenay M; Jourdi G
Int J Lab Hematol; 2019 Dec; 41(6):738-744. PubMed ID: 31487115
[TBL] [Abstract][Full Text] [Related]
3. The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants.
Ząbczyk M; Kopytek M; Natorska J; Undas A
Clin Chem Lab Med; 2019 Aug; 57(9):1374-1381. PubMed ID: 30763261
[TBL] [Abstract][Full Text] [Related]
4. Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome.
Arachchillage DR; Mackie IJ; Efthymiou M; Isenberg DA; Machin SJ; Cohen H
J Thromb Haemost; 2015 Jul; 13(7):1264-73. PubMed ID: 25850997
[TBL] [Abstract][Full Text] [Related]
5. Frequent false-positive results of lupus anticoagulant tests in plasmas of patients receiving the new oral anticoagulants and enoxaparin.
Martinuzzo ME; Barrera LH; D 'adamo MA; Otaso JC; Gimenez MI; Oyhamburu J
Int J Lab Hematol; 2014 Apr; 36(2):144-50. PubMed ID: 24034808
[TBL] [Abstract][Full Text] [Related]
6. Rivaroxaban Therapy, False-Positive Lupus Anticoagulant Screening Results, and Confirmatory Assay Results.
Murer LM; Pirruccello SJ; Koepsell SA
Lab Med; 2016 Nov; 47(4):275-278. PubMed ID: 27474775
[TBL] [Abstract][Full Text] [Related]
7. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
[TBL] [Abstract][Full Text] [Related]
8. Applying index of circulating anticoagulant to mixing tests with lupus anticoagulant screen and confirm reagents can distinguish with high specificity between lupus anticoagulants and direct factor Xa inhibitors.
Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
Int J Lab Hematol; 2021 Aug; 43(4):771-778. PubMed ID: 33974363
[TBL] [Abstract][Full Text] [Related]
9. Paired APTTs of low and high lupus anticoagulant sensitivity permit distinction from other abnormalities and achieve good lupus anticoagulant detection rates in conjunction with dRVVT.
Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
Int J Lab Hematol; 2019 Feb; 41(1):60-68. PubMed ID: 30248243
[TBL] [Abstract][Full Text] [Related]
10. Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting.
Antovic A; Norberg EM; Berndtsson M; Rasmuson A; Malmström RE; Skeppholm M; Antovic J
Thromb Haemost; 2017 Aug; 117(9):1700-1704. PubMed ID: 28640321
[TBL] [Abstract][Full Text] [Related]
11. Newly developed dilute Russell's viper venom reagents for lupus anticoagulant detection with improved specificity.
Moore GW; Peyrafitte M; Dunois C; Amiral J
Lupus; 2018 Jan; 27(1):95-104. PubMed ID: 28549386
[TBL] [Abstract][Full Text] [Related]
12. Lupus-anticoagulant testing at NOAC trough levels.
Ratzinger F; Lang M; Belik S; Jilma-Stohlawetz P; Schmetterer KG; Haslacher H; Perkmann T; Quehenberger P
Thromb Haemost; 2016 Aug; 116(2):235-40. PubMed ID: 27075441
[TBL] [Abstract][Full Text] [Related]
13. Rivaroxaban and false positive lupus anticoagulant testing.
Merriman E; Kaplan Z; Butler J; Malan E; Gan E; Tran H
Thromb Haemost; 2011 Feb; 105(2):385-6. PubMed ID: 21103666
[No Abstract] [Full Text] [Related]
14. Taipan snake venom time coupled with ecarin time enhances lupus anticoagulant detection in nonanticoagulated patients.
Moore GW; Culhane AP; Maloney JC; Archer RA; Breen KA; Hunt BJ
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):477-80. PubMed ID: 26656903
[TBL] [Abstract][Full Text] [Related]
15. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA.
Tripodi A; Chantarangkul V; Clerici M; Mannucci PM
Thromb Haemost; 2002 Oct; 88(4):583-6. PubMed ID: 12362227
[TBL] [Abstract][Full Text] [Related]
16. Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulants.
Jourdi G; Delrue M; Stepanian A; Valaize J; Foulon-Pinto G; Demagny J; Duchemin J; Nedelec-Gac F; Darnige L; Curis E; Delavenne X; Gaussem P; Siguret V; Gouin-Thibault I
Thromb Res; 2019 Dec; 184():86-91. PubMed ID: 31710863
[TBL] [Abstract][Full Text] [Related]
17. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
18. Comparison of six dilute russell viper venom time lupus anticoagulant screen/confirm assay kits.
McGlasson DL; Fritsma GA
Semin Thromb Hemost; 2013 Apr; 39(3):315-9. PubMed ID: 23468380
[TBL] [Abstract][Full Text] [Related]
19. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant.
Sakakura M; Wada H; Watanabe R; Mamamuro M; Okugawa Y; Nakasaki T; Nakase T; Wakita Y; Minamikawa K; Mori Y; Nshikawa M; Shiku H
Clin Appl Thromb Hemost; 2000 Jul; 6(3):144-50. PubMed ID: 10898274
[TBL] [Abstract][Full Text] [Related]
20. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies.
Proven A; Bartlett RP; Moder KG; Chang-Miller A; Cardel LK; Heit JA; Homburger HA; Petterson TM; Christianson TJ; Nichols WL
Mayo Clin Proc; 2004 Apr; 79(4):467-75. PubMed ID: 15065611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
